Baker Bros. Advisors’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-3,125
Closed -$1.24M 111
2018
Q2
$1.24M Hold
3,125
0.01% 103
2018
Q1
$955K Sell
3,125
-6,332
-67% -$1.94M 0.01% 101
2017
Q4
$2.78M Sell
9,457
-203
-2% -$59.7K 0.02% 92
2017
Q3
$5.29M Hold
9,660
0.04% 77
2017
Q2
$5.76M Buy
9,660
+3,803
+65% +$2.27M 0.05% 63
2017
Q1
$2.52M Hold
5,857
0.02% 84
2016
Q4
$3.01M Sell
5,857
-108
-2% -$55.6K 0.03% 77
2016
Q3
$2.55M Hold
5,965
0.02% 88
2016
Q2
$2.5M Buy
+5,965
New +$2.5M 0.03% 90